Patent application number | Description | Published |
20080261972 | Cgrp Receptor Antagonists - Compounds of Formula (I), (where variables R | 10-23-2008 |
20090192139 | CGRP RECEPTOR ANTAGONISTS - The present invention is directed to compounds of Formula I: | 07-30-2009 |
20100266714 | P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN - The subject invention relates to novel P2X | 10-21-2010 |
20110206783 | P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN - The subject invention relates to novel P2X | 08-25-2011 |
20120015052 | P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN - The subject invention relates to novel P2X | 01-19-2012 |
20120064181 | P2X3 Receptor Antagonists for Treatment of Pain - The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator. | 03-15-2012 |
20120122899 | PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS - The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. | 05-17-2012 |
20120122900 | PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS - The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. | 05-17-2012 |
20130267541 | FUSED HETEROCYCLIC AZAINDANE CARBOXAMIDE CGRP RECEPTOR ANTAGONISTS - The present invention is directed to fused heterocyclic azaindane carboxamide derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. | 10-10-2013 |
20150031716 | PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS - The present invention is directed to piperidinone carboxamide indane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. | 01-29-2015 |